HDFC Securities Results Report 11-Oct-24
HDFC Securities Results Report 11-Oct-24
HDFC Securities Results Report 11-Oct-24
improved to 5.5% YoY CC (following 3.4% CC growth in FY24). TCS’ Q2 Bloomberg code TCS IN
growth was impacted by client-specific scope reduction in the Life-sciences & No. of Shares (mn) 3,618
Healthcare vertical/NorthAm (expected to stabilize & recover in Q3-Q4
MCap (INR bn) / ($ mn) 15,295/182,133
period) and a large customer in the UK geography. BFSI vertical (37% of
revenue) posted its strongest sequential growth over three years at 2.7% QoQ. 6m avg traded value (INR mn) 10,471
Deal wins in the BFSI vertical also increased to USD 2.9bn in Q2 with book- 52 Week high / low INR 4,492/3,296
to-bill improving over Q1 and above the overall bookings. Key drivers of
spend include cost optimization, vendor consolidation, ERP modernization,
STOCK PERFORMANCE (%)
customer experience transformation, supply chain modernization, and
regulatory compliance. The insurance sub-segment is also growing with deals 3M 6M 12M
such as Trygg-Hansa IT estate consolidation and transformation. Absolute (%) 8.1 6.1 17.0
▪ Growth skew from BSNL deal continued; absolute EBIT impact limited Relative (%) 6.0 (2.7) (6.5)
ahead: Growth in the quarter continued to be driven by India/BSNL/CMT
which contributed ~70% of the sequential growth, which was similar to the
SHAREHOLDING PATTERN (%)
mix of the last three quarters. The company has reached the halfway mark for
the rollout of the 4G/5G network for 100k sites that are to be deployed. While Mar-24 Jun-24
the impact of revenue rate dropping post deployment will be material Promoters 71.77 71.77
(factored in Q4FY25E-Q1FY26E), we reckon the absolute EBIT impact is FIs & Local MFs 10.67 11.05
contained on cost normalizing and continuity in maintenance revenue. Deal
FPIs 12.70 12.35
wins improved slightly to USD 8.6bn total contract value in Q2, but lower YoY
with the absence of mega deals (H1FY24 included 2 mega deals of USD 1bn Public & Others 4.86 4.83
each from JLR and BSNL). Pledged Shares 0.20 0.20
Source: BSE
Apurva Prasad
Financial Summary
[email protected]
YE March (INR bn) Q2FY25 Q2FY24 YoY (%) Q1FY25 QoQ (%) FY24 FY25E FY26E FY27E
+91-22-6171-7327
Revenue (USD mn) 7,670 7,210 6.4 7,505 2.2 29,080 30,804 32,814 35,401
Net Sales 642.59 596.92 7.7 626.13 2.6 2,408.93 2,581.58 2,789.16 3,044.48 Amit Chandra
EBIT 154.65 144.83 6.8 154.42 0.1 593.11 640.67 724.34 792.48 [email protected]
APAT 119.09 113.42 5.0 120.40 (1.1) 466.35 498.28 562.24 613.87 +91-22-6171-7345
Diluted EPS (INR) 32.9 31.3 5.0 33.3 (1.1) 128.9 137.7 155.4 169.7
Vinesh Vala
P/E (x) 32.8 30.7 27.2 24.9
[email protected]
EV / EBITDA (x) 23.1 21.5 19.0 17.4
RoE (%) 51.6 54.4 59.0 60.4
+91-22-6171-7332
Source: Company, HSIE Research
HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters
Tata Consultancy Services: Results Review Q2FY25
▪ Traction in GenAI & Growth market investments: Sequential growth drag for the
quarter was from the Life-sciences & Healthcare vertical which declined 4.4% and
by Manufacturing and Retail & Consumer which were flat sequentially. On a YoY
basis, E&U and Manufacturing verticals led the growth. There’s traction in
AI/GenAI with the company deploying 600+ AI/GenAI POCs/engagements in
production and there’s demand for AI-infused services (as compared to 275 in Q1).
Importantly 86 engagements went into production in Q2. TCS’ WisdomNext
platform for enterprises and investments in AI experience zones and labs with
open-source technologies and key large language models from AWS, Google, and
Microsoft can support acceleration. TCS plans to increase its footprint in growth
markets – India, APAC, LatAm and MEA regions and is investing to build scale in
these regions. While bookings in NorthAm were lower at USD 4.2bn TCV (vs. USD
4.6bn), Europe & RoW had bookings of USD 4.4bn vs. 3.7bn in Q1.
▪ Underwhelming operating performance, but on track trajectory: Operating
performance was impacted by a continued surge in investments for the large
transformation program, particularly margin-dilutive BSNL deal. EBITM came at
24.1%, -60bps QoQ impacted by (1) -160bps QoQ on account of an increase in
hardware/software cost (INR 11bn increase sequentially), (2) an increase in sub-
contracting impacting margins by -40bps QoQ. Margin impact from the BSNL deal
has peaked and is expected to normalise more materially in FY26E. APAT at INR
119bn was down sequentially and up 5% YoY impacted by lower other income.
DSO including unbilled remained steady sequentially. We have factored EBITM at
24.8% for FY25E with Q4 exit at 25.8%; and factored FY26/27E EBITM at 26% each.
Hardware/software cost is the biggest tailwind for FY26E margin improvement
which will support profit acceleration to 13% in FY25E and 10% CAGR over FY24-
27E.
▪ Headcount adds similar to last quarter: Headcount addition was at a similar clip
as last quarter with 5.7k net adds taking the count to 613k with attrition stable at
12.3%. Learning hours increase of 10% YoY and 37% QoQ reflects an uptick in
fresher intake by the company – it is on track for FY25 fresher adds and has started
the NQT (National Qualifier Test) for FY26 fresher offers.
▪ Outlook and Valuation: TCS’s earnings trajectory has been least volatile over the
past two years, posting double-digit CAGR, and we expect a ~10% EPS CAGR to
continue ahead. We expect TCS’ growth to accelerate from 3.4% CC in FY24 to 5.5%
CC, 6.3% CC and 7.9% CC in FY25E, FY26E & FY27E respectively, implying 1.7%
CQGR in FY25/26E and 1.9% in FY27E. We have factored EBITM at 24.8% for
FY25E with Q4 exit at 25.8%; factored FY26/27E EBITM at 26% each, translating to
10% EPS CAGR over FY24-27E. TCS trades at 27x FY26E, 25x FY27E and our TP of
INR 4,650 is based on 28x Dec-26E EPS —which is in line with its 5Y average
multiples of 27x (10Y average at 23.5x). Higher earnings resilience and return
ratios, payout yield at ~3.5%, FCF yield at 4%, and industry-leading
execution/quality metrics support valuation.
▪ Key highlights from earnings call: (1) FY25 deal bookings can be closer to the
FY25 mark. (2) Optimism is driven by the work backlog of the customer. (3) Easing
of rate environment, consumer confidence can potentially lead to improved tech
investments. (4) Near-term pressure in Manufacturing vertical with labour and
supply side constraints, but strong long-term trends of Smart manufacturing and
software-defined vehicles. (5) Furlough impact is expected to be similar to last
year. (6) Margin exit at 26% - similar to FY24. (7) SG&A leverage is a margin lever
for the company as growth picks up. (8) Profit margin in the growth market is
lower than the major market.
Page | 2
Tata Consultancy Services: Results Review Q2FY25
Margin Analysis
Q2 Q2 YoY Q1 QoQ H1 H1 YoY
MARGIN ANALYSIS
FY25 FY24 (bps) FY25 (bps) FY25 FY24 (bps)
Employee Expenses % Net
57.0 58.8 -180 58.2 -112 57.6 59.0 -142
Revenues
Other Operating Expenses %
16.9 14.8 214 15.2 169 16.1 15.2 92
Net Revenues
EBITDA Margin (%) 26.0 26.4 -34 26.6 -57 26.3 25.8 50
EBIT Margin (%) 24.1 24.3 -20 24.7 -60 24.4 23.7 65
Tax Rate (%) 25.4 25.8 -34 25.4 1 25.4 25.8 -36
APAT Margin (%) 18.5 19.0 -47 19.2 -70 18.9 18.8 5
Source: Company, HSIE Research
Page | 3
Tata Consultancy Services: Results Review Q2FY25
Exhibit 2: Revenue growth trend improving vs Exhibit 3: Growth recovery expected with stable margin
Accenture (including inorganic) in FY25E
Exhibit 4: Margin declined -60bps sequentially Exhibit 5: Higher cost of equipment due to BSNL deal
ramp up
Exhibit 6: Scope to normalise employee expense & hardware cost with improvement in pyramid
% of revenue FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 H1FY25
Employee expense 52.2% 53.9% 53.4% 54.8% 55.9% 56.1% 56.6% 58.2% 57.6%
Cost of hardware & software license 2.4% 2.2% 1.5% 1.2% 0.9% 0.6% 0.8% 1.5% 4.2%
Fees to external consultant 7.5% 7.3% 7.7% 8.2% 8.0% 9.1% 9.5% 6.6% 4.5%
Facility expense 3.1% 3.2% 2.9% 1.7% 1.3% 1.1% 1.2% 1.3% 1.3%
Travel expense 2.4% 2.3% 2.4% 2.1% 0.7% 0.8% 1.2% 1.2% 1.3%
Others 5.0% 4.7% 5.0% 5.1% 4.8% 4.6% 4.5% 4.5% 4.7%
Depreciation & Amortisation 1.7% 1.6% 1.4% 2.2% 2.5% 2.4% 2.2% 2.1% 2.0%
EBIT 25.7% 24.8% 25.6% 24.6% 25.9% 25.3% 24.1% 24.6% 24.4%
Source: Company, HSIE Research
Page | 4
Tata Consultancy Services: Results Review Q2FY25
Page | 5
Tata Consultancy Services: Results Review Q2FY25
Exhibit 10: Improving trend of USD 100mn+ clients Exhibit 11: Growth across client bucket
Page | 6
Tata Consultancy Services: Results Review Q2FY25
Page | 7
Tata Consultancy Services: Results Review Q2FY25
(YoY Growth, % CC) Q4FY23 Q1FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q2FY25
BFSI 9.1 3.0 (0.5) (3.0) (3.2) (0.9) 0.1
Consumer Business 13.0 5.3 1.0 (0.3) (0.3) (0.3) 0.1
Communication & Media 5.3 0.5 (2.1) (4.9) (5.5) (7.4) (10.3)
Manufacturing 9.1 9.4 5.8 7.0 9.7 9.4 5.3
Life Sciences & Healthcare 12.3 10.1 5.0 3.1 1.7 4.0 0.1
Energy & Utilities NA NA 14.8 11.8 7.3 5.7 7.0
Technology & Services 9.2 4.4 (2.2) (5.0) (5.6) (3.9) (1.9)
Regional Markets & Others 14.6 16.7 14.3 19.2 26.0 37.7 50.4
Total 10.7 7.0 2.8 1.7 2.2 4.4 5.5
Source: Company, HSIE Research
Page | 8
Tata Consultancy Services: Results Review Q2FY25
(YoY Growth, % CC) Q4FY23 Q1FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q2FY25
North America 9.6 4.6 0.1 (3.0) (2.3) (1.1) (2.1)
Latin America 15.1 13.5 13.1 13.2 9.8 6.3 6.8
UK 17.0 16.1 10.7 8.1 6.2 6.0 4.6
Continental Europe 8.4 3.4 1.3 0.5 (2.0) 0.9 1.8
Asia-Pacific 7.5 4.7 4.1 3.9 5.2 7.6 7.5
India 13.4 14.0 3.9 23.4 37.9 61.8 95.2
Middle East and Africa 11.3 15.2 15.9 16.0 10.7 8.5 7.9
Total 10.7 7.0 2.8 1.7 2.2 4.4 5.5
Source: Company, HSIE Research
Page | 9
Tata Consultancy Services: Results Review Q2FY25
Exhibit 22: TCS P/E (1-yr fwd) Trend Exhibit 23: TCS trading at ~4% discount to NIFTY IT (vs
historical premium ~15%)
P/E (1-yr fwd) 10 Yr Mean NIFTY NSEIT TCS
SD 1SD + 38.0
1SD - 2SD +
40 33.0
35 28.3
28.0
P/E (x)
30
23.0
P/E (x)
25
18.0
20
15 13.0
10 8.0 Apr-15
Apr-16
Apr-18
Apr-20
Apr-22
Apr-17
Apr-19
Apr-21
Apr-23
Apr-24
Apr-15
Apr-17
Apr-18
Apr-20
Apr-21
Apr-24
Apr-16
Apr-19
Apr-22
Apr-23
Oct-16
Oct-17
Oct-18
Oct-19
Oct-21
Oct-23
Oct-24
Oct-15
Oct-17
Oct-18
Oct-19
Oct-20
Oct-21
Oct-22
Oct-24
Oct-15
Oct-20
Oct-22
Oct-16
Oct-23
Exhibit 24: Earnings resilience relative to peers Exhibit 25: Superior execution will support premium
valuations
TCS Infosys
Wipro HCL Tech 26.0 24.9
105
FY26E Consensus EPS (INR)
23.4 23.0
24.0 22.6
100 22.0
FY27E P/E (x)
19.3
95 20.0
18.0
90
16.0
85
14.0
80
12.0
Apr-23
Apr-24
Jun-23
Jun-24
Feb-24
Mar-24
Jul-23
Jan-24
Sep-23
Oct-23
Jul-24
Sep-24
May-23
May-24
Aug-23
Nov-23
Aug-24
Dec-23
10.0
TCS Infosys Wipro HCL Tech Accenture
Source: Bloomberg, HSIE Research Source: HSIE Research, Note: Accenture is Bloomberg consensus P/E
Page | 10
Tata Consultancy Services: Results Review Q2FY25
Financials
Consolidated Income Statement
YE March (INR bn) FY23 FY24 FY25E FY26E FY27E
Net Sales (USD mn) 27,927 29,080 30,804 32,814 35,401
Growth (%) 8.6 4.1 5.9 6.5 7.9
Net Sales 2,254.58 2,408.93 2,581.58 2,789.16 3,044.48
Growth (%) 17.6 6.8 7.2 8.0 9.2
Employee Expenses 1,275.22 1,401.31 1,475.19 1,593.49 1,737.54
SG&A and Other Expenses 386.77 364.66 414.09 415.54 453.58
EBIDTA 592.59 642.96 692.30 780.13 853.36
Depreciation 50.22 49.85 51.63 55.78 60.89
EBIT 542.37 593.11 640.67 724.34 792.48
EBIT (%) 24.1 24.6 24.8 26.0 26.0
EBIT Growth (%) 11.9 9.4 8.0 13.1 9.4
Other Income 34.49 44.22 38.69 42.61 44.04
Interest 7.79 7.78 8.03 9.35 9.35
PBT 569.07 629.55 671.34 757.61 827.16
Tax (incl deferred) 146.04 158.98 170.95 193.19 210.93
Minority Interest and associate profit 1.56 1.91 2.11 2.17 2.37
RPAT 421.47 459.08 498.28 562.24 613.87
APAT 421.47 466.35 498.28 562.24 613.87
APAT Growth (%) 10.0 10.6 6.8 12.8 9.2
EPS (INR) 116.5 128.9 137.7 155.4 169.7
EPS Growth (%) 10.0 10.6 6.8 12.8 9.2
Source: Company, HSIE Research
Page | 11
Tata Consultancy Services: Results Review Q2FY25
Key Ratios
FY23 FY24 FY25E FY26E FY27E
PROFITABILITY (%)
EBITDA Margin 26.3 26.7 26.8 28.0 28.0
APAT Margin 18.7 19.4 19.3 20.2 20.2
RoE 46.9 51.6 54.4 59.0 60.4
RoIC or Core RoCE 90.7 88.7 88.6 93.2 94.6
RoCE 44.5 48.7 51.4 55.8 57.1
EFFICIENCY
Tax Rate (%) 25.7 25.3 25.5 25.5 25.5
Fixed Asset Turnover (x) 7.0 7.1 7.2 7.3 7.7
Debtors (days) 67 68 68 67 67
Other Current Asset (days) 33 36 34 33 31
Payables (days) 17 15 15 15 15
Other Current Liab & Prov (days) 53 55 52 49 47
Cash Conversion Cycle (days) 29 33 35 36 37
Net Debt/EBITDA (x) (0.8) (0.7) (0.6) (0.6) (0.6)
Net Debt/Equity (x) (0.5) (0.5) (0.5) (0.5) (0.5)
Interest Coverage (x) 70 76 80 77 85
PER SHARE DATA
EPS (INR/sh) 116.5 128.9 137.7 155.4 169.7
CEPS (INR/sh) 128.9 142.7 152.0 170.8 186.5
DPS (INR/sh) 115.0 73.0 132.0 140.0 150.0
BV (INR/sh) 241 241 247 262 280
VALUATION
P/E 36.3 32.8 30.7 27.2 24.9
P/BV 17.5 17.5 17.1 16.2 15.1
EV/EBITDA 25.0 23.1 21.5 19.0 17.4
OCF/EV (%) 3.0 3.2 3.6 4.0 4.4
FCF/EV (%) 2.8 2.9 3.6 4.0 4.4
FCFE/mkt cap (%) 2.6 2.8 3.4 3.8 4.2
Dividend Yield (%) 2.7 1.7 3.1 3.3 3.5
Source: Company, HSIE Research
Page | 12
Tata Consultancy Services: Results Review Q2FY25
1 Yr Price Movement
TCS
4800
4600
4400
4200
4000
3800
3600
3400
Rating Criteria
3200
BUY: >+15% return potential
3000
ADD: +5% to +15% return potential
Nov-23
Apr-24
Mar-24
Dec-23
Jan-24
Feb-24
May-24
Aug-24
Sep-24
Oct-23
Jun-24
Oct-24
Jul-24
REDUCE: -10% to +5% return potential
SELL: > 10% Downside return potential
Page | 13
Tata Consultancy Services: Results Review Q2FY25
Disclosure:
We, Apurva Prasad, MBA, Amit Chandra, MBA & Vinesh Vala, MBA authors and the names subscribed to this report,
hereby certify that all of the views expressed in this research report accurately reflect my views about the subject issuer(s)
or securities. SEBI conducted the inspection and based on their observations have issued advise/warning. The said
observations have been complied with. I also certify that no part of my compensation was, is, or will be directly or
indirectly related to the specific recommendation(s) or view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company.
Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or
more in the subject company at the end of the month immediately preceding the date of publication of the Research
Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does have/does not have any
material conflict of interest.
Any holding in stock – No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must
not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider
the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional
advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this
document should make such investigations as they deem necessary to arrive at an independent evaluation of an
investment in securities of the companies referred to in this document (including merits and risks) and should consult
their own advisors to determine merits and risks of such investment. The information and opinions contained herein have
been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such
information has not been independently verified and no guaranty, representation of warranty, express or implied, is made
as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice.
Descriptions of any company or companies or their securities mentioned herein are not intended to be complete. HSL is
not obliged to update this report for such changes. HSL has the right to make changes and modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by,
any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such
distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject
HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the
same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or
published in whole or in part, directly or indirectly, for any purposes or in any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could
have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such
as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be
considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or
other financial instruments. This report should not be construed as an invitation or solicitation to do business with HSL.
HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail
and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position
in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving
such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the
company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other
potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages
sustained due to the investments made or any action taken on basis of this report, including but not restricted to,
fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the
dividend or income, etc.
Page | 14
Tata Consultancy Services: Results Review Q2FY25
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks,
securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities
from time to time or may deal in other securities of the companies / organizations described in this report. As regards the
associates of HSL please refer the website.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might
have been mandated by the subject company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the
period preceding twelve months from the date of this report for services in respect of managing or co-managing public
offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a
merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or
third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have
any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not
based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued
other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served
as an officer, director or employee of the subject company. We have not received any compensation/benefits from the
subject company or third party in connection with the Research Report.
Please note that HDFC Securities has a proprietary trading desk. This desk maintains an arm’s length distance with the
Research team and all its activities are segregated from Research activities. The proprietary desk operates independently,
potentially leading to investment decisions that may deviate from research views.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp.
Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Murli V Karkera Email: [email protected] Phone: (022) 3045 3600
For grievance redressal contact Customer Care Team Email: [email protected] Phone: (022) 3901 9400
HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg.
No. POP: 11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI
Investment Adviser Reg. No.: INA000011538; CIN - U67120MH2000PLC152193
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before
investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee
performance of the intermediary or provide any assurance of returns to investors.
HDFC Securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board: +91-22-6171-7330 www.hdfcsec.com
Page | 15
11 October 2024 Results Review Q2FY25
Tata Elxsi
Mixed vertical trends REDUCE
Tata Elxsi’s (TELX) performance continued to exhibit a similar trend of strength
CMP (as on 10 Oct 2024) INR 7,759
in the Transportation vertical (56% of revenue), offset by weakness in the
Target Price INR 6,925
Media & Communications vertical and the Healthcare vertical. Growth in T5
declined sequentially, a first in three years. Deal momentum in Transportation NIFTY 24,998
(incl. USD 50mn TCV deal) and an increased mix of OEMs can maintain the
growth outperformance. While the Healthcare vertical can recover by FY25E- KEY
OLD NEW
end, Media & Communications could take longer. We continue to believe that CHANGES
T1 client growth momentum and OEM sub-segment within the Transportation Rating REDUCE REDUCE
segment will drive the bulk of the growth over FY24-26E. While the growth Price Target INR 7,120 INR 6,925
trajectory is expected to improve ahead, valuations are still a stretch; maintain
FY26E FY27E
REDUCE with a TP of INR 6,925, based on 38x Dec-26E EPS. EPS %
-2.6 -2.8
▪ Transportation vertical robust performance: TELX’s Transportation vertical
continues to post strong growth supported by an increasing mix of OEM
within the vertical – in Q2 OEM’s share of revenue stood at 68%. Growth in KEY STOCK DATA
the vertical is supported by TELX’s capabilities in software-defined vehicles, Bloomberg code TELX IN
ADAS and Connected. TELX is now embedded in the SDV programs of five
No. of Shares (mn) 62
global OEMs and has worked with over 30 OEMs globally. The key deal win
included USD 50mn TCV from European OEM for software-defined and MCap (INR bn) / ($ mn) 483/5,754
other components of automotive engineering. TELX’s deal wins in the vertical 6m avg traded value (INR mn) 1,926
are likely to support continued growth momentum in the vertical – we’re 52 Week high / low INR 9,200/6,407
factoring 20% growth CAGR for the Transportation vertical in FY25E and
FY26E led by growth in JLR and OEM portfolio while the tier-1 sub-segment
is estimated to decline 5% in FY25E. Within geos, growth in Q2 was largely STOCK PERFORMANCE (%)
driven by India/RoW regions. 3M 6M 12M
▪ Weakness in Media & Communications vertical persists: Media & Absolute (%) 9.0 (1.1) 5.4
Communications vertical performance was weaker than expected at -2.6%
Relative (%) 6.9 (9.9) (18.1)
QoQ CC and was impacted by delays and industry-related factors of lower
subscriber growth and cutback in discretionary. TELX’s media &
communication vertical (32% of revenue) has been underperforming, SHAREHOLDING PATTERN (%)
following a strong FY20-22 and later, a weak FY22-24. Within the vertical, the Mar-24 Jun-24
mix of customers has improved with operators accounting for >70% of
Promoters 43.92 43.92
revenue, but challenges in the industry persist. Key win in the vertical
included the setup of AI CoE for AI-led transformation for a Middle-east FIs & Local MFs 6.06 6.24
operator. TELX’s media & communication portfolio has seen a shift over the FPIs 14.56 13.67
years from having a high share of device vendors earlier to now a higher share Public & Others 35.46 36.17
from operators. TELX has strong partnerships and competencies in areas of
Pledged Shares 0.00 0.00
RDK and Android TV supporting areas of nex-gen entertainment, broadband
and connectivity along with its IP portfolio. We’ve factored the vertical to Source: BSE
decline by 2% for FY25E and recover to double-digit subsequently.
Apurva Prasad
Financial Summary [email protected]
YE March (INR bn) Q2FY25 Q2FY24 YoY (%) Q1FY25 QoQ (%) FY24 FY25E FY26E FY27E
+91-22-6171-7327
Revenue (USD Mn) 114 107 6.8 111 2.6 429 466 540 622
Net Sales 9.55 8.82 8.3 9.26 3.1 35.52 39.08 45.89 53.48 Amit Chandra
EBIT 2.39 2.39 0.3 2.25 6.2 9.47 10.23 12.44 14.59 [email protected]
APAT 2.29 2.00 14.7 1.84 24.6 7.92 8.60 10.11 11.79 +91-22-6171-7345
Diluted EPS (INR) 36.8 32.1 14.7 29.6 24.6 127.2 138.1 162.4 189.4
P/E (x) 61.0 56.2 47.8 41.0 Vinesh Vala
EV / EBITDA (x) 44.7 41.0 33.7 28.6 [email protected]
RoE (%) 34.5 31.9 32.4 32.6 +91-22-6171-7332
Source: Company, HSIE Research
HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters
Tata Elxsi: Results Review Q2FY25
Page | 2
Tata Elxsi: Results Review Q2FY25
Page | 3
Tata Elxsi: Results Review Q2FY25
Page | 4
Tata Elxsi: Results Review Q2FY25
Exhibit 4: New segmental structure (SDS) Exhibit 5: EPD & IDV combined to drive larger
programs
Q2FY25 FY24
QoQ %, YoY %, YoY %,
(Revenue (Revenue
CC CC CC
USD mn) USD mn)
Transportation - SDS 61.6 4.4 16.0 207.9 20.4
Media &
35.2 (2.6) (5.1) 147.1 -2.6
Communications - SDS
Healthcare& Life
12.7 (11.2) (11.8) 58.3 7.6
Sciences - SDS
Others -SDS 1.1 33.0 35.9 3.3 2.9
Total Software
Development & 110.7 0.2 4.8 416.7 9.3
Services (SDS)
System Integration &
3.3 (1.2) 15.2 12.0 18.6
Support (SIS)
Source: Company, HSIE Research, Note SDS denotes Software Source: Company, HSIE Research
Development & Services (erstwhile EPD+IDV)
Page | 5
Tata Elxsi: Results Review Q2FY25
US continues to decline
Growth QoQ % Q1FY24 Q2FY24 Q3FY24 Q4FY24 Q1FY25 Q2FY25
for the 4th consecutive
Europe 7.0 10.2 4.2 -1.3 6.8 3.7
quarter impacted by
USA -1.3 1.5 -2.8 -4.5 -4.5 -7.9
Media &
India -0.3 -5.9 8.9 4.5 3.9 9.6
Communication
RoW -7.3 -4.6 19.7 9.5 5.4 31.0
vertical
Total 1.5 3.2 2.9 -1.0 2.1 2.6
Page | 6
Tata Elxsi: Results Review Q2FY25
Exhibit 11: Steady EBITDA margin supported by lower dependence on sub-contracting & high offshore
Page | 7
Tata Elxsi: Results Review Q2FY25
Exhibit 14: TELX valuations vs other ER&D peers Exhibit 15: TELX P/E (1-yr fwd) Trend
P/E (1-yr fwd) 10 Yr Mean
SD 1SD +
1SD - 2SD +
100
53.4
75
50
P/E (x)
25
-25
Feb-20
Jun-15
Jun-22
Mar-17
Mar-24
Apr-21
Jan-16
Jul-19
Jan-23
Sep-20
Aug-16
Aug-23
Oct-17
Oct-24
Nov-14
May-18
Nov-21
Dec-18
Source: Bloomberg, HSIE Research Source: Bloomberg, HSIE Research
Source: Company, HSIE Research, Note: FY22 included special dividend of INR 24, KPITTECH & TATATECH (Not rated) as per Bloomberg Consensus
Page | 8
Tata Elxsi: Results Review Q2FY25
Financials
Consolidated Income Statement
YE March (INR bn) FY23 FY24 FY25E FY26E FY27E
Net Revenues (USD mn) 390 429 466 540 622
Growth (%) 17.7 9.9 8.8 15.8 15.2
Net Revenues 31.45 35.52 39.08 45.89 53.48
Growth (%) 27.3 13.0 10.0 17.4 16.5
Employee Expenses 15.98 19.10 20.70 24.13 28.29
SG&A Expenses 5.86 5.96 7.04 8.03 9.09
EBITDA 9.61 10.46 11.34 13.73 16.09
EBITDA Margin (%) 30.6 29.5 29.0 29.9 30.1
EBITDA Growth (%) 25.5 8.9 8.4 21.0 17.2
Depreciation 0.81 0.99 1.11 1.28 1.50
EBIT 8.80 9.47 10.23 12.44 14.59
Other Income (Including EO Items) 0.74 1.22 1.59 1.42 1.54
Interest 0.16 0.20 0.19 0.19 0.19
PBT 9.38 10.49 11.63 13.67 15.94
Tax (Incl Deferred) 1.82 2.56 3.03 3.55 4.14
RPAT 7.55 7.92 8.60 10.11 11.79
APAT 7.55 7.92 8.60 10.11 11.79
APAT Growth (%) 37.4 4.9 8.6 17.6 16.6
Adjusted EPS (INR) 121.3 127.2 138.1 162.4 189.4
EPS Growth (%) 37.4 4.9 8.6 17.6 16.6
Source: Company, HSIE Research
Page | 9
Tata Elxsi: Results Review Q2FY25
Key Ratios
FY23 FY24 FY25E FY26E FY27E
PROFITABILITY (%)
GPM 49.2 46.2 47.0 47.4 47.1
EBITDA Margin 30.6 29.5 29.0 29.9 30.1
APAT Margin 24.0 22.3 22.0 22.0 22.1
RoE 41.0 34.5 31.9 32.4 32.6
RoIC (or Core RoCE) 83.0 63.7 59.9 64.7 65.7
RoCE 38.2 32.4 30.0 30.8 31.2
EFFICIENCY
Tax Rate (%) 19.4 24.5 26.0 26.0 26.0
Fixed Asset Turnover (x) 8.4 8.8 8.8 8.8 8.8
Debtors (days) 113 100 100 100 100
Other Current Assets (days) 17 21 21 21 21
Payables (days) 12 9 9 9 9
Other Current Liab & Provns (days) 44 37 36 35 34
Cash Conversion Cycle (days) 75 75 76 78 79
Debt/EBITDA (x) - - - - -
Net D/E (x) (0.6) (0.6) (0.6) (0.6) (0.6)
Interest Coverage (x) 54 47 53 64 75
PER SHARE DATA (INR)
EPS 121.3 127.2 138.1 162.4 189.4
CEPS 134 143 156 183 213
Dividend 61 70 76 89 104
Book Value 335 402 465 538 623
VALUATION
P/E (x) 64.0 61.0 56.2 47.8 41.0
P/BV (x) 23.2 19.3 16.7 14.4 12.5
EV/EBITDA (x) 49.0 44.7 41.0 33.7 28.6
OCF/EV (%) 1.0 1.5 1.6 1.9 2.2
FCF/EV (%) 0.9 1.3 1.3 1.5 1.8
FCFE/Mkt Cap (%) 0.8 1.2 1.2 1.4 1.6
Dividend Yield (%) 0.8 0.9 1.0 1.2 1.3
Source: Company, HSIE Research
Page | 10
Tata Elxsi: Results Review Q2FY25
1 Yr Price Movement
Tata Elxsi
9500
9000
8500
8000
7500
7000
6500 Rating Criteria
6000 BUY: >+15% return potential
Sep-24
Jan-24
Feb-24
Mar-24
Apr-24
May-24
Aug-24
Jul-24
Oct-23
Nov-23
Oct-24
Jun-24
Page | 11
Tata Elxsi: Results Review Q2FY25
Disclosure:
We, Apurva Prasad, MBA, Amit Chandra, MBA & Vinesh Vala, MBA authors and the names subscribed to this report,
hereby certify that all of the views expressed in this research report accurately reflect my views about the subject issuer(s)
or securities. SEBI conducted the inspection and based on their observations have issued advise/warning. The said
observations have been complied with. I also certify that no part of my compensation was, is, or will be directly or
indirectly related to the specific recommendation(s) or view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company.
Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or
more in the subject company at the end of the month immediately preceding the date of publication of the Research
Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does have/does not have any
material conflict of interest.
Any holding in stock – No
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must
not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider
the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional
advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this
document should make such investigations as they deem necessary to arrive at an independent evaluation of an
investment in securities of the companies referred to in this document (including merits and risks) and should consult
their own advisors to determine merits and risks of such investment. The information and opinions contained herein have
been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such
information has not been independently verified and no guaranty, representation of warranty, express or implied, is made
as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice.
Descriptions of any company or companies or their securities mentioned herein are not intended to be complete. HSL is
not obliged to update this report for such changes. HSL has the right to make changes and modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by,
any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such
distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject
HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the
same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or
published in whole or in part, directly or indirectly, for any purposes or in any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could
have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such
as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be
considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or
other financial instruments. This report should not be construed as an invitation or solicitation to do business with HSL.
HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail
and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position
in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving
such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the
company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other
potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages
sustained due to the investments made or any action taken on basis of this report, including but not restricted to,
fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the
dividend or income, etc.
Page | 12
Tata Elxsi: Results Review Q2FY25
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks,
securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities
from time to time or may deal in other securities of the companies / organizations described in this report. As regards the
associates of HSL please refer the website.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might
have been mandated by the subject company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the
period preceding twelve months from the date of this report for services in respect of managing or co-managing public
offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a
merger or specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or
third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have
any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not
based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued
other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served
as an officer, director or employee of the subject company. We have not received any compensation/benefits from the
subject company or third party in connection with the Research Report.
Please note that HDFC Securities has a proprietary trading desk. This desk maintains an arm’s length distance with the
Research team and all its activities are segregated from Research activities. The proprietary desk operates independently,
potentially leading to investment decisions that may deviate from research views.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp.
Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Murli V Karkera Email: [email protected] Phone: (022) 3045 3600
For grievance redressal contact Customer Care Team Email: [email protected] Phone: (022) 3901 9400
HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg.
No. POP: 11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI
Investment Adviser Reg. No.: INA000011538; CIN - U67120MH2000PLC152193
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before
investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee
performance of the intermediary or provide any assurance of returns to investors.
HDFC Securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board: +91-22-6171-7330 www.hdfcsec.com
Page | 13
10 October 2024 Q2FY25 Results Preview
Sustenance of demand pick-up during the festive season remains a key Havells 1,929 2,000 ADD
increasing mix in favour of high-volume low-margin business will lead to a dip V-Guard 440 420 REDUCE
in margins over LY, leading to EBITDA/PAT growth of 61/82%. Voltas 1,792 1,775 ADD
HSIE Research is also available on Bloomberg ERH HDF <GO> & Thomson Reuters
Consumer Durables & EMS: Q2FY25 Results Preview
Page | 2
Consumer Durables & EMS: Q2FY25 Results Preview
Page | 3
Consumer Durables & EMS: Q2FY25 Results Preview
Exhibit 5: Copper prices up 11% YoY; down 5% QoQ Exhibit 6: Aluminum prices up 12% YoY; down 5% QoQ
Copper (INR/KG) Aluminium (INR/KG)
1000 350
300
800
250
600 200
150
400
100
200
50
0 0
Mar-17
Mar-18
Mar-19
Mar-20
Mar-21
Mar-22
Mar-23
Mar-24
Sep-17
Sep-16
Sep-18
Sep-19
Sep-20
Sep-21
Sep-22
Sep-23
Sep-24
Sep-17
Sep-23
Sep-16
Sep-18
Sep-19
Sep-20
Sep-21
Sep-22
Sep-24
Mar-21
Mar-17
Mar-18
Mar-19
Mar-20
Mar-22
Mar-23
Mar-24
Source: Bloomberg Source: Bloomberg
Exhibit 7: Rupee has depreciated by 1% YoY Exhibit 8: HDPE prices have risen 5% YoY; flat QoQ
USD/INR Polypropylene (INR/kg)
90.0
140
85.0
120
80.0
100
75.0
80
70.0
60
65.0
40
60.0
55.0 20
50.0 0
Mar-17
Mar-18
Mar-19
Mar-20
Mar-21
Mar-22
Mar-23
Mar-24
Sep-20
Sep-16
Sep-17
Sep-18
Sep-19
Sep-21
Sep-22
Sep-23
Sep-24
Sep-20
Sep-16
Sep-17
Sep-18
Sep-19
Sep-21
Sep-22
Sep-23
Sep-24
Mar-21
Mar-17
Mar-18
Mar-19
Mar-20
Mar-22
Mar-23
Mar-24
Page | 4
0
10000
20000
5000
15000
100
200
400
500
300
0
0
1000
1500
200
400
600
BUY:
ADD:
SELL:
Oct-23 Oct-23 Oct-23 Oct-23
Nov-23 Nov-23 Nov-23 Nov-23
Dec-23 Dec-23 Dec-23 Dec-23
Jan-24 Jan-24 Jan-24 Jan-24
Rating Criteria
Feb-24 Feb-24 Feb-24 Feb-24
1 Yr Price history
Dixon
Apr-24 Apr-24 Apr-24 Apr-24
V-Guard
May-24 May-24 May-24 May-24
Orient Electric
Bajaj Electricals
500
0
1000
2000
1500
0
1000
2000
3000
Oct-23
Apr-24
May-24 May-24 May-24
May-24
Jun-24 Jun-24
Jun-24 Jun-24
Kaynes Technology
Jul-24 Jul-24
Jul-24 Jul-24
Crompton Consumer
Aug-24 Aug-24
Aug-24 Aug-24
Sep-24 Sep-24
Sep-24 Sep-24
Oct-24 Oct-24
Oct-24 Oct-24
200
400
800
600
0
0
2000
4000
6000
500
0
1000
1500
0
1000
2000
3000
Oct-23
Oct-23
Oct-23 Oct-23
Nov-23
Nov-23 Nov-23 Nov-23
Dec-23
Dec-23 Dec-23 Dec-23
Jan-24
Jan-24 Jan-24 Jan-24
Feb-24
Feb-24 Feb-24 Feb-24
Mar-24
Mar-24 Mar-24 Mar-24
Apr-24 Apr-24
Apr-24
Syrma
Apr-24
Amber
May-24
TTK Prestige
May-24
Havells India
May-24 May-24
Jun-24 Jun-24 Jun-24 Jun-24
Jul-24 Jul-24
Jul-24 Jul-24
Aug-24 Aug-24 Aug-24
Aug-24
Sep-24 Sep-24 Sep-24
Sep-24
Oct-24 Oct-24
Oct-24 Oct-24
Page | 5
Consumer Durables & EMS: Q2FY25 Results Preview
Disclosure:
I, Paarth Gala, BCom author and the name subscribed to this report, hereby certify that all of the views expressed in this
research report accurately reflect our views about the subject issuer(s) or securities. SEBI conducted the inspection and
based on their observations have issued advise/warning. The said observations have been complied with. We also certify
that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or
view(s) in this report.
Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company.
Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or
more in the subject company at the end of the month immediately preceding the date of publication of the Research Report.
Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does have/does not have any material
conflict of interest.
Any holding in stock – NO
HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475.
Disclaimer:
This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must
not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider
the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice
before investing. Nothing in this document should be construed as investment advice. Each recipient of this document
should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in
securities of the companies referred to in this document (including merits and risks) and should consult their own advisors
to determine merits and risks of such investment. The information and opinions contained herein have been compiled or
arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not
been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy,
completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any
company or companies or their securities mentioned herein are not intended to be complete. HSL is not obliged to update
this report for such changes. HSL has the right to make changes and modifications at any time.
This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by,
any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such
distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject
HSL or its affiliates to any registration or licensing requirement within such jurisdiction.
If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the
same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or
published in whole or in part, directly or indirectly, for any purposes or in any manner.
Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could
have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as
ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be
considered to be taken as an offer to sell or a solicitation to buy any security.
This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or
other financial instruments. This report should not be construed as an invitation or solicitation to do business with HSL.
HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail
and/or its attachments.
HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position
in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving
such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the
company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other
potential conflict of interests with respect to any recommendation and other related information and opinions.
HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages
sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation
in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or
income, etc.
Page | 6
Consumer Durables & EMS: Q2FY25 Results Preview
HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks,
securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from
time to time or may deal in other securities of the companies / organizations described in this report. As regards the
associates of HSL please refer the website.
HSL or its associates might have managed or co-managed public offering of securities for the subject company or might
have been mandated by the subject company for any other assignment in the past twelve months.
HSL or its associates might have received any compensation from the companies mentioned in the report during the period
preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings,
corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or
specific transaction in the normal course of business.
HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third
party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any
material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based
on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other
reports that are inconsistent with and reach different conclusion from the information presented in this report.
Research entity has not been engaged in market making activity for the subject company. Research analyst has not served
as an officer, director or employee of the subject company. We have not received any compensation/benefits from the
subject company or third party in connection with the Research Report.
Please note that HDFC Securities has a proprietary trading desk. This desk maintains an arm’s length distance with the
Research team and all its activities are segregated from Research activities. The proprietary desk operates independently,
potentially leading to investment decisions that may deviate from research views.
HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp.
Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066
Compliance Officer: Murli V Karkera Email: [email protected] Phone: (022) 3045 3600
For grievance redressal contact Customer Care Team Email: [email protected] Phone: (022) 3901 9400
HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg.
No. POP: 11092018; IRDA Corporate Agent License No.: CA0062; SEBI Research Analyst Reg. No.: INH000002475; SEBI
Investment Adviser Reg. No.: INA000011538; CIN - U67120MH2000PLC152193
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before
investing.
Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee
performance of the intermediary or provide any assurance of returns to investors.
HDFC Securities
Institutional Equities
Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park,
Senapati Bapat Marg, Lower Parel, Mumbai - 400 013
Board: +91-22-6171-7330 www.hdfcsec.com
Page | 7